Effect of Imatinib Mesylate Combined with Granulocyte Colony-Stimulating Factor on Leukaemic Blast Cells Derived from Advanced-Stage Chronic Myelogenous Leukaemia Patients

Publisher： Karger

E-ISSN： 1421-9662|116|1|8-18

ISSN： 0001-5792

Source： Acta Haematologica, Vol.116, Iss.1, 2006-07, pp. : 8-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-04 ,pp. : 192-197

Karger

Access to resources Recommend Favorite

Promyelocytic Crisis of Chronic Myelogenous Leukaemia during Imatinib Mesylate Treatment

By  

Acta Haematologica, Vol. 117, Iss. 4, 2006-12 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia

By  

Acta Haematologica, Vol. 118, Iss. 4, 2007-11 ,pp. : 205-208

Karger

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-Stimulating Factor and Interferon-Alpha 2B in Patients with Advanced Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 4, 1999-06 ,pp. : 215-219

Karger

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor and leukemogenesis

By Lorena Lobo de Figueiredo   Rodrigo Siqueira de Abreu e Lima   Eduardo Magalhães Rego  

Mediators of Inflammation, Vol. 13, Iss. 3, 2004-06 ,pp. : 145-150

Informa Healthcare

Access to resources Recommend Favorite